Kelly represents issuers, underwriters, and investors on a wide variety of corporate finance transactions, from initial public offerings and traditional bank finance transactions to SPACs, equity securities deals, and high-yield bond issuances. He also has extensive experience leading specialized transactions such as leveraged acquisitions, liability management transactions, corporate restructurings, and recapitalizations for corporates, funds, and investment banks.
Steven M. Skolnick, Chair of the Capital Markets & Securities practice and Vice Chair of the firm’s Transactions & Advisory Group, says: “Jared offers a sophisticated perspective on all stages of the company lifecycle to clients across the biotech, energy, fintech, and other industries. He is also ideally suited to advise investment banks and strategic investors on innovative growth strategies, as well as the latest in regulatory and financial markets trends.”
“Lowenstein’s strategic focus on technology, life sciences, and investment funds has made the firm a key player in these areas, where I, too, aim to expand my practice. Joining Lowenstein makes perfect sense for me because of our shared visions,” says Kelly.
Before joining Lowenstein, Kelly was a partner at Reed Smith LLP. He received his J.D. and an LL.M. in Securities & Financial Regulation from the Georgetown University Law Center and his B.S., magna cum laude, from Florida State University.
About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.
Stephen J. Kimmerling
Director, Marketing Communications
Lowenstein Sandler LLP
T: +1 973.597.6176